Literature DB >> 16239125

Interventions with neuroprotective agents: novel targets and opportunities.

Patrick G Sullivan1.   

Abstract

Several antiepileptic drugs have demonstrated neuroprotective properties in animal models by inhibiting the components of the excitotoxic cascade. The process of neurodegeneration appears to be dependent on the mitochondria, with their central role as regulators of both energy metabolism and apoptotic pathways during seizures. Excess cytosolic Ca(2+) during periods of excitotoxicity disrupts homeostasis in the mitochondria, causing inhibition of adenosine triphosphate synthesis and increased production of reactive oxygen species, with resultant oxidative damage, leading to neuronal cell death. The Ca(2+)-mediated mitochondrial dysfunction in epilepsy may be the main target for neuroprotective intervention by antiepileptic drugs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16239125     DOI: 10.1016/j.yebeh.2005.08.004

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  4 in total

1.  Therapeutic window analysis of the neuroprotective effects of cyclosporine A after traumatic brain injury.

Authors:  Patrick G Sullivan; Andrea H Sebastian; Edward D Hall
Journal:  J Neurotrauma       Date:  2011-02-02       Impact factor: 5.269

2.  Cyclosporin A preserves mitochondrial function after traumatic brain injury in the immature rat and piglet.

Authors:  Todd J Kilbaugh; Sunita Bhandare; David H Lorom; Manda Saraswati; Courtney L Robertson; Susan S Margulies
Journal:  J Neurotrauma       Date:  2011-04-12       Impact factor: 5.269

Review 3.  Targeting mitochondrial dysfunction in CNS injury using Methylene Blue; still a magic bullet?

Authors:  Hemendra J Vekaria; Lora Talley Watts; Ai-Ling Lin; Patrick G Sullivan
Journal:  Neurochem Int       Date:  2017-04-07       Impact factor: 3.921

4.  Targeting deficiencies in mitochondrial respiratory complex I and functional uncoupling exerts anti-seizure effects in a genetic model of temporal lobe epilepsy and in a model of acute temporal lobe seizures.

Authors:  Kristina A Simeone; Stephanie A Matthews; Kaeli K Samson; Timothy A Simeone
Journal:  Exp Neurol       Date:  2013-11-21       Impact factor: 5.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.